Works matching IS 00126667 AND DT 2021 AND VI 81 AND IP 16
Results: 13
Correction to: Contezolid: First Approval.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Sotorasib: First Approval.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Interchangeability of Biosimilars: Overcoming the Final Hurdles.
- Published in:
- Drugs, 2021, v. 81, n. 16, p. 1897, doi. 10.1007/s40265-021-01629-4
- By:
- Publication type:
- Article
Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density.
- Published in:
- Drugs, 2021, v. 81, n. 16, p. 1831, doi. 10.1007/s40265-021-01625-8
- By:
- Publication type:
- Article
Difelikefalin: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 16, p. 1937, doi. 10.1007/s40265-021-01619-6
- By:
- Publication type:
- Article
Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease.
- Published in:
- Drugs, 2021, v. 81, n. 16, p. 1821, doi. 10.1007/s40265-021-01616-9
- By:
- Publication type:
- Article
Disitamab Vedotin: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 16, p. 1929, doi. 10.1007/s40265-021-01614-x
- By:
- Publication type:
- Article
Avatrombopag: A Review in Thrombocytopenia.
- Published in:
- Drugs, 2021, v. 81, n. 16, p. 1905, doi. 10.1007/s40265-021-01613-y
- By:
- Publication type:
- Article
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
- Published in:
- Drugs, 2021, v. 81, n. 16, p. 1859, doi. 10.1007/s40265-021-01610-1
- By:
- Publication type:
- Article
Belzutifan: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 16, p. 1921, doi. 10.1007/s40265-021-01606-x
- By:
- Publication type:
- Article
Donafenib: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 16, p. 1915, doi. 10.1007/s40265-021-01603-0
- By:
- Publication type:
- Article
Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective.
- Published in:
- Drugs, 2021, v. 81, n. 16, p. 1881, doi. 10.1007/s40265-021-01601-2
- By:
- Publication type:
- Article